305 related articles for article (PubMed ID: 6950671)
1. [Effect of 15-methyl-prostaglandin F2 alpha used for dilating the cervix uteri before abortion on endogenous prostaglandin F2 alpha synthesis].
Goncharova VN; Morozova MS; Razina LG; Manuilova IA; Murashko LE
Akush Ginekol (Mosk); 1981 Dec; (12):37-8. PubMed ID: 6950671
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study. World Health Organization Tast Force on the Use of Prostaglandins forthe Regulation of Fertility.
Am J Obstet Gynecol; 1977 Nov; 129(6):601-6. PubMed ID: 920761
[TBL] [Abstract][Full Text] [Related]
3. Preoperative dilatation of the cervix by single vaginal administration of 15-methyl-PGF2alpha-methyl ester.
Ganguli AC; Gréen K; Bygdeman M
Prostaglandins; 1977 Oct; 14(4):779-84. PubMed ID: 339282
[TBL] [Abstract][Full Text] [Related]
4. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
5. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
6. Cervical dilatation by Lamicel--studies on the mechanism of action.
Nicolaides KH; Welch CC; Koullapis EN; Filshie GM
Br J Obstet Gynaecol; 1983 Nov; 90(11):1060-4. PubMed ID: 6688953
[TBL] [Abstract][Full Text] [Related]
7. Dilatation of the cervix prior to vacuum aspiration by single vaginal administration of 15-methyl-PGF2 alpha methyl ester.
Frankman O; Bygdeman M; Gréen K; Moberg P; Sandberg CG
Contraception; 1980 Jun; 21(6):571-6. PubMed ID: 7428365
[TBL] [Abstract][Full Text] [Related]
8. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
[TBL] [Abstract][Full Text] [Related]
9. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
Marrs RP; Brenner PF; Roy S; Mishell DR
Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
[TBL] [Abstract][Full Text] [Related]
10. Cervical dilatation in late first trimester termination by prostaglandin, hylase and isogel.
Mandlekar AV; Ganguli AC; Krishna UR; Purandare VN
Prostaglandins Med; 1981 Apr; 6(4):381-7. PubMed ID: 7025067
[TBL] [Abstract][Full Text] [Related]
11. Abortifacient effect and uterine cervix-dilating action of 16, 16-dimethyl trans delta 2 PGE1 methyl ester (ONO 802) in the form of a vaginal suppository (a randomized, double-blind, controlled study in the second trimester of pregnancy).
Sakamoto S; Satoh K; Nishiya I; Kunimoto K; Chimura T; Oda T; Takeuchi S; Satoh Y; Iizuka R; Kobayashi T; Takagi S; Yoshida T; Tomoda Y; Ninagawa T; Kurachi K; Tanizawa O; Tojo S; Mochizuki M; Maeda K; Tominaga Y; Torigoe T; Koresawa M; Taki I; Hamada T
Prostaglandins Leukot Med; 1982 Sep; 9(3):349-61. PubMed ID: 6752961
[TBL] [Abstract][Full Text] [Related]
12. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
Bolognese RJ; Corson SL
Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F2 alpha, oxytocin, and uterine activation in hypertonic saline-induced abortions.
Fuchs AR; Rasmussen AB; Rehnström J; Toth M
Am J Obstet Gynecol; 1984 Sep; 150(1):27-32. PubMed ID: 6476024
[TBL] [Abstract][Full Text] [Related]
14. Vaginally administered PGF2alpha for cervical dilatation in nulliparas prior to suction curettage.
Brenner WE; Dingfelder JR; Staurovsky LG; Hendricks CH
Prostaglandins; 1973 Dec; 4(6):819-36. PubMed ID: 4783581
[TBL] [Abstract][Full Text] [Related]
15. Internal and external cervical os dilation with vaginal 15-methyl prostaglandin F2 alpha.
Fayemi A; Schulman H; Mitchell J; Fleischer A
Am J Obstet Gynecol; 1983 May; 146(2):219-20. PubMed ID: 6846441
[TBL] [Abstract][Full Text] [Related]
16. The use of prostaglandin E1 analogue pessaries in patients having first trimester induced abortions.
Nakano R; Hata H; Sasaki K; Yamoto M
Br J Obstet Gynaecol; 1980 Apr; 87(4):287-91. PubMed ID: 7426498
[TBL] [Abstract][Full Text] [Related]
17. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
Roux JF; Southern E; Gutknecht G
Contraception; 1980 Jul; 22(1):57-61. PubMed ID: 7418407
[TBL] [Abstract][Full Text] [Related]
18. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
Karim SM; Choo HT; Cheng P
Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
[TBL] [Abstract][Full Text] [Related]
19. Dilatation of the cervix by oral PGE2 before first-trimester termination of pregnancy.
Somell C; Olund A; Kindahl H; Larsson B
Acta Obstet Gynecol Scand; 1984; 63(7):625-8. PubMed ID: 6393687
[TBL] [Abstract][Full Text] [Related]
20. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
Roy S; Brenner PF; Marrs RP; Mishell DR
Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
